Eloxx Pharmaceuticals, Inc.
ELOX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001035354
No open-market purchases or sales by Eloxx Pharmaceuticals, Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $34.7M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Eloxx Pharmaceuticals, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- −2 vs. Q3 2021
- Shares held
- 16.5M
- +422.3K (+2.6%) vs. Q3 2021
- Total value
- $11.7M
- −$14.4M (−55.2%) vs. Q3 2021
- New holders
- 10
- 8 more added
- Sold out
- 12
- 14 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELOX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 22 | $34.7M |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 1 | $0 |
| Q2 2024 | 1 | $43 |
| Q1 2024 | 1 | $62 |
| Q4 2023 | 4 | $109.0K |
| Q3 2023 | 18 | $2.50M |
| Q2 2023 | 16 | $924.2K |
| Q1 2023 | 19 | $671.5K |
| Q4 2022 | 19 | $476.7K |
| Q3 2022 | 32 | $2.14M |
| Q2 2022 | 32 | $3.51M |
| Q1 2022 | 36 | $8.42M |
| Q4 2021 | 39 | $11.7M |
| Q3 2021 | 41 | $26.0M |
| Q2 2021 | 47 | $33.2M |
| Q1 2021 | 38 | $28.7M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Eloxx Pharmaceuticals, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 3,037,489 | $2.14M | 0.00% | −9,549−0.3% | Reduced |
| Menora Mivtachim Holdings Ltd. | 2,094,208 | $1.48M | 0.02% | 00.0% | Unchanged |
| Silverarc Capital Management, LLC | 1,930,092 | $1.36M | 0.61% | +670,252+53.2% | Added |
| American Financial Group Inc | 1,480,000 | $1.04M | 0.29% | 00.0% | Unchanged |
| Harel Insurance Investments & Financial Services Ltd. | 1,176,401 | $831.0K | 0.02% | +1,176,401 | New |
| Altshuler Shaham Ltd | 1,157,540 | $828.0K | 0.02% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 894,659 | $632.0K | 0.04% | −314,679−26.0% | Reduced |
| Geode Capital Management, LLC | 798,058 | $558.0K | 0.00% | +25,222+3.3% | Added |
| Clal Insurance Enterprises Holdings Ltd | 585,000 | $413.0K | 0.00% | 00.0% | Unchanged |
| Anson Funds Management LP | 553,652 | $391.0K | 0.05% | +553,652 | New |
| BlackRock Inc. | 508,135 | $360.0K | 0.00% | +17,264+3.5% | Added |
| Two Sigma Advisers, LP | 468,000 | $331.0K | 0.00% | −237,300−33.6% | Reduced |
| Bridgeway Capital Management, LLC | 309,400 | $217.0K | 0.00% | +218,000+238.5% | Added |
| State Street Corp | 182,003 | $127.0K | 0.00% | −12,400−6.4% | Reduced |
| Millennium Management LLC | 175,564 | $123.0K | 0.00% | −98,733−36.0% | Reduced |
| Vanguard Capital Wealth Advisors | 158,900 | $111.0K | 0.08% | −279,000−63.7% | Reduced |
| Bank of New York Mellon Corp | 146,291 | $103.0K | 0.00% | +70,169+92.2% | Added |
| Virtu Financial LLC | 130,270 | $91.0K | 0.01% | +130,270 | New |
| Northern Trust Corp | 124,369 | $88.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 117,729 | $83.0K | 0.00% | −197,145−62.6% | Reduced |
| Atom Investors LP | 113,151 | $80.0K | 0.02% | +113,151 | New |
| B. Riley Wealth Management, Inc. | 48,500 | $34.0K | 0.00% | +48,500 | New |
| Wells Fargo & Company | 46,670 | $33.0K | 0.00% | +25,300+118.4% | Added |
| Group One Trading, L.P. | 44,772 | $31.0K | 0.00% | +44,772 | New |
| Simplex Trading, LLC | 43,198 | $30.0K | 0.00% | −52,504−54.9% | Reduced |
| Susquehanna International Group, LLP | 34,652 | $25.0K | 0.00% | −10,392−23.1% | Reduced |
| Occudo Quantitative Strategies LP | 29,492 | $21.0K | 0.00% | −12,150−29.2% | Reduced |
| Rafferty Asset Management, LLC | 26,072 | $18.0K | 0.00% | +26,072 | New |
| Citadel Advisors LLC | 22,350 | $16.0K | 0.00% | −81,938−78.6% | Reduced |
| D. E. Shaw & Co., Inc. | 21,295 | $15.0K | 0.00% | −42,403−66.6% | Reduced |
| Bank of America Corp | 17,223 | $12.0K | 0.00% | +11,146+183.4% | Added |
| Two Sigma Securities, LLC | 17,499 | $12.0K | 0.00% | +17,499 | New |
| Advisor Group Holdings, Inc. | 12,359 | $9.00K | 0.00% | 00.0% | Unchanged |
| Victory Capital Management Inc | 10,791 | $8.00K | 0.00% | −329−3.0% | Reduced |
| Tower Research Capital LLC (TRC) | 9,596 | $7.00K | 0.00% | +9,596 | New |
| Morgan Stanley | 3,691 | $2.00K | 0.00% | +2,898+365.4% | Added |
| BNP Paribas Arbitrage, SA | 647 | $457 | 0.00% | −75−10.4% | Reduced |
| JPMorgan Chase & Co | 41 | $0 | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 6 | $0 | 0.00% | +6 | New |
| Altium Capital Management LP | 0 | $0 | 0.00% | −1,118,000−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −103,900−100.0% | Sold out |
| Private Advisor Group, LLC | 0 | $0 | 0.00% | −32,510−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −27,588−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −25,778−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −22,700−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −19,720−100.0% | Sold out |
| Mesirow Financial Investment Management, Inc. | 0 | $0 | 0.00% | −18,894−100.0% | Sold out |
| Sawtooth Solutions, LLC | 0 | $0 | 0.00% | −16,201−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −3,678−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −338−100.0% | Sold out |
| Brewin Dolphin Ltd | 0 | $0 | 0.00% | −15−100.0% | Sold out |